Periostin is an extracellular matrix (ECM)
protein that is overexpressed in a variety of human
cancers, and its functions appear to be linked to
tumor growth,
metastasis, and angiogenesis. Recent clinical evidence suggests that aberrant
periostin expression is correlated with poor outcome in patients with
breast cancer. To identify novel tools to regulate the functional role of
periostin, we generated benzyl-d(U)TP-modified
DNA aptamers that were directed against human
periostin (PNDAs) and characterized their functional roles in
breast cancer progression. PNDA-3 selectively bound to the FAS-1 domain of
periostin with nanomolar affinity and disrupted the interaction between
periostin and its
cell surface receptors, αvβ3 and αvβ5
integrins. PNDA-3 markedly antagonized the
periostin-induced adhesion, migration, and invasion of
breast cancer cells and blocked the activation of various components of the αvβ3 and αvβ5
integrin signal transduction pathways. In a 4T1 orthotopic mouse model, PNDA-3 administration significantly reduced primary
tumor growth and distant
metastasis. Thus, our results demonstrated that
periostin-
integrin signaling regulates
breast cancer progression at multiple levels in
tumor cells and the tumor microenvironment.
DNA aptamers targeting
periostin may potentially be used to inhibit
breast cancer progression.